Lista de obras -

Adjuvant systemic treatment in hepatocellular carcinoma: tempted to do something, rather than nothing

artículo científico publicado en 2020

BILCAP trial and adjuvant capecitabine in resectable biliary tract cancer: reflections on a standard of care

scientific article published on 13 December 2020

Current Strategies and Novel Therapeutic Approaches for Metastatic Urothelial Carcinoma

scientific article published on 02 June 2020

Dose reduction and discontinuation of standard-dose regorafenib associated with adverse drug events in cancer patients: a systematic review and meta-analysis

artículo científico publicado en 2020

Evolution of the Experimental Models of Cholangiocarcinoma

artículo científico publicado en 2020

Experimental HER2 targeted therapies for biliary tract cancer

artículo científico publicado en 2020

Genomic Database Analysis of Uterine Leiomyosarcoma Mutational Profile

artículo científico publicado en 2020

Granular cell tumor of the trachea as a rare cause of dyspnea in a young woman

scientific article published on 25 October 2019

Immortal time bias in the association between toxicity and response for immune checkpoint inhibitors: a meta-analysis

artículo científico publicado en 2020

Immunotherapy in Biliary Tract Cancer: Worthy of a Second Look

artículo científico publicado en 2020

Impact of Chemotherapy in the Adjuvant Setting of Early Stage Uterine Leiomyosarcoma: A Systematic Review and Updated Meta-Analysis

artículo científico publicado en 2020

Is There a Role for Immunotherapy in Prostate Cancer?

scientific article published on 08 September 2020

Lean Perspectives in an Organizational Change in a Scientific Direction of an Italian Research Institute: Experience of the Cancer Institute of Bari

artículo científico publicado en 2022

Nivolumab: an investigational agent for the treatment of biliary tract cancer

scientific article published on 12 December 2020

PARP Inhibitors in Biliary Tract Cancer: A New Kid on the Block?

scientific article published on 31 August 2020

Recent advances of immunotherapy for biliary tract cancer

artículo científico publicado en 2020

Regarding "HER2 overexpression as a poor prognostic determinant in resected biliary tract cancer" by Vivaldi et al

artículo científico publicado en 2020

Targeting BRAF-Mutant Biliary Tract Cancer: Recent Advances and Future Challenges

artículo científico publicado en 2020

The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancer

artículo científico publicado en 2020

Third- and later-line treatment in advanced or metastatic gastric cancer: a systematic review and meta-analysis

scientific article published on 03 December 2019

Lista de obras de

Adjuvant systemic treatment in hepatocellular carcinoma: tempted to do something, rather than nothing

BILCAP trial and adjuvant capecitabine in resectable biliary tract cancer: reflections on a standard of care

Current Strategies and Novel Therapeutic Approaches for Metastatic Urothelial Carcinoma

Dose reduction and discontinuation of standard-dose regorafenib associated with adverse drug events in cancer patients: a systematic review and meta-analysis

Evolution of the Experimental Models of Cholangiocarcinoma

Experimental HER2 targeted therapies for biliary tract cancer

Genomic Database Analysis of Uterine Leiomyosarcoma Mutational Profile

Granular cell tumor of the trachea as a rare cause of dyspnea in a young woman

Immortal time bias in the association between toxicity and response for immune checkpoint inhibitors: a meta-analysis

Immunotherapy in Biliary Tract Cancer: Worthy of a Second Look

Impact of Chemotherapy in the Adjuvant Setting of Early Stage Uterine Leiomyosarcoma: A Systematic Review and Updated Meta-Analysis

Is There a Role for Immunotherapy in Prostate Cancer?

Lean Perspectives in an Organizational Change in a Scientific Direction of an Italian Research Institute: Experience of the Cancer Institute of Bari

Nivolumab: an investigational agent for the treatment of biliary tract cancer

PARP Inhibitors in Biliary Tract Cancer: A New Kid on the Block?

Recent advances of immunotherapy for biliary tract cancer

Regarding "HER2 overexpression as a poor prognostic determinant in resected biliary tract cancer" by Vivaldi et al

Targeting BRAF-Mutant Biliary Tract Cancer: Recent Advances and Future Challenges

The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancer

Third- and later-line treatment in advanced or metastatic gastric cancer: a systematic review and meta-analysis